MRK - Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership | Benzinga
On Friday, Judge Thomas Rose, serving in the U.S. District Court for the Southern District of Ohio, opted to step down from the case on the same day the Revolving Door Project, a nonprofit organization, revealed his ownership of stocks in Johnson & Johnson (NYSE: JNJ) and AstraZeneca Plc (NASDAQ: AZN).
The Revolving Door Project expressed concerns about Judge Rose's apparent conflict of interest in the pharmaceutical industry and urged him to recuse himself.
Among the ten drugs subject to price negotiations this year, as unveiled by the Biden administration, are ...